欧洲软骨退行性市场预测至 2027 年 - COVID-19 影响和按手术类型(骨软骨移植、软骨成形术、关节置换、半月板移植、细胞软骨表面置换等)进行的区域分析;应用(膝盖、臀部和其他);和最终用户(医院和专科诊所、门诊手术中心以及学术和研究机构)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 110    |    Report Code: TIPRE00014168    |    Category: Life Sciences

Europe Cartilage Degeneration Market

市场介绍

软骨退变会导致人体关节疼痛和慢性炎症。此外,受损的软骨可能会影响患者的生活质量。持续的研究和开发正在创新处理受损软骨的新技术和方法。其中一些技术包括关节置换术、细胞疗法和软骨成形术。

市场概况和动态

欧洲软骨退化市场预计将从 2019 年的 24.6316 亿美元增至 2027 年的 33.6509 亿美元;预计2020年至2027年复合年增长率为4.1%。运动损伤和肥胖症患病率的增加预计将推动欧洲软骨退行性市场的增长。然而,市场增长受到软骨治疗成本高和缺乏报销方案的影响。

关键细分市场

从手术类型来看,关节置换细分市场在2019年欧洲软骨退变市场中占据最大份额。 从应用来看,膝关节细分在2019年欧洲软骨退变市场中占据最大份额。用户、医院和2019年,专科诊所细分市场占欧洲软骨退行性病变市场的最大份额。

主要来源和上市公司

准备本亚太软骨退行性市场报告时参考的一些主要一手和二手资料来源包括世界卫生组织 (WHO)、英国运动医学杂志、欧洲运动创伤学会、膝关节外科、关节镜 (ESSKA) )、经济合作与发展组织(OECD)、 及其他

< span>购买报告的理由

  • 了解欧洲软骨退化市场格局并确定最有可能的细分市场保证丰厚的回报。
  • 了解该地区不断变化的竞争格局,保持领先地位
  • 高效通过识别最有希望销售的细分市场,规划欧洲软骨退行性病变市场的并购和合作交易
  • 通过对市场表现的敏锐和全面分析,做出明智的业务决策各个细分市场
  • 获得2019年-2027年期间基于各个细分市场的市场收入预测

欧洲软骨退变市场细分

按手术类型

  • 关节置换术
  • 软骨成形术
  • < li>细胞软骨表面重建
  • 骨软骨移植
  • 半月板移植
  • 其他

 < /strong>

按用途

  • 膝盖
  • 臀部
  • 其他

 

最终用户

  • 医院和医疗机构专科诊所
  • 门诊手术中心
  • 学术与医疗中心研究机构

 

按国家划分

  • 德国< /li>
  • 英国
  • 法国
  • 意大利
  • 西班牙

公司简介

  • B.布劳恩梅尔松根股份公司
  • Smith &侄子
  • Stryker Corporation
  • CartiHeal, Inc
  • Vericel Corporation

 < /p>

 

 



Europe Cartilage Degeneration Strategic Insights

Strategic insights for Europe Cartilage Degeneration involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-cartilage-degeneration-market-strategic-framework.webp
Get more information on this report

Europe Cartilage Degeneration Report Scope

Report Attribute Details
Market size in 2019 US$ 2,463.16 Million
Market Size by 2027 US$ 3,365.09 Million
Global CAGR (2020 - 2027) 4.1%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 手术类型
  • 骨软骨移植
  • 软骨成形术
  • 关节置换
  • 半月板移植
  • 细胞软骨置换
By 应用
  • 膝盖
  • 臀部
By 最终用户
  • 医院和专科诊所
  • 门诊手术中心
  • 学术和研究机构
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • B. Braun Melsungen AG
  • Smith & Nephew
  • Stryker Corporation
  • CartiHeal, Inc
  • Vericel Corporation
  • Get more information on this report

    Europe Cartilage Degeneration Regional Insights

    The regional scope of Europe Cartilage Degeneration refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-cartilage-degeneration-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Cartilage Degeneration Market

    The List of Companies - Europe Cartilage Degeneration Market

    1. B. Braun Melsungen AG
    2. Smith & Nephew
    3. Stryker Corporation
    4. CartiHeal, Inc
    5. Vericel Corporation

     

    Frequently Asked Questions
    How big is the Europe Cartilage Degeneration Market?

    The Europe Cartilage Degeneration Market is valued at US$ 2,463.16 Million in 2019, it is projected to reach US$ 3,365.09 Million by 2027.

    What is the CAGR for Europe Cartilage Degeneration Market by (2020 - 2027)?

    As per our report Europe Cartilage Degeneration Market, the market size is valued at US$ 2,463.16 Million in 2019, projecting it to reach US$ 3,365.09 Million by 2027. This translates to a CAGR of approximately 4.1% during the forecast period.

    What segments are covered in this report?

    The Europe Cartilage Degeneration Market report typically cover these key segments-

  • 手术类型 (骨软骨移植, 软骨成形术, 关节置换, 半月板移植, 细胞软骨置换)
  • 应用 (膝盖, 臀部)
  • 最终用户 (医院和专科诊所, 门诊手术中心, 学术和研究机构)
  • What is the historic period, base year, and forecast period taken for Europe Cartilage Degeneration Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cartilage Degeneration Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Europe Cartilage Degeneration Market?

    The Europe Cartilage Degeneration Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun Melsungen AG
  • Smith & Nephew
  • Stryker Corporation
  • CartiHeal, Inc
  • Vericel Corporation
  • Who should buy this report?

    The Europe Cartilage Degeneration Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Cartilage Degeneration Market value chain can benefit from the information contained in a comprehensive market report.